199 related articles for article (PubMed ID: 21719060)
21. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
[TBL] [Abstract][Full Text] [Related]
22. Oral insulin stimulates intestinal epithelial cell turnover following massive small bowel resection in a rat and a cell culture model.
Ben Lulu S; Coran AG; Shehadeh N; Shamir R; Mogilner JG; Sukhotnik I
Pediatr Surg Int; 2012 Feb; 28(2):179-87. PubMed ID: 21986618
[TBL] [Abstract][Full Text] [Related]
23. DPP4 inhibitor reinforces cell junction proteins in mouse model of short bowel syndrome.
Sueyoshi R; Miyahara K; Nakazawa-Tanaka N; Fujiwara N; Ochi T; Yamataka A
Pediatr Surg Int; 2020 Jan; 36(1):49-55. PubMed ID: 31576468
[TBL] [Abstract][Full Text] [Related]
24. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat.
Mogilner JG; Srugo I; Lurie M; Shaoul R; Coran AG; Shiloni E; Sukhotnik I
J Pediatr Surg; 2007 Aug; 42(8):1365-71. PubMed ID: 17706498
[TBL] [Abstract][Full Text] [Related]
25. Plasma GLP-2 levels and intestinal markers in the juvenile pig during intestinal adaptation: effects of different diet regimens.
Paris MC; Fuller PJ; Carstensen B; Nagy E; Taylor RG; Sourial M; Holst JJ; Hartmann B; Binesm JE
Dig Dis Sci; 2004 Oct; 49(10):1688-95. PubMed ID: 15573929
[TBL] [Abstract][Full Text] [Related]
26. Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport.
Goto M; Furuta S; Yamashita S; Hashimoto H; Yano W; Inoue N; Kato N; Kaku K
J Diabetes Investig; 2018 Nov; 9(6):1261-1269. PubMed ID: 29754453
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor 2 and its enterocyte receptor are not required for adaptation in response to massive small bowel resection.
Sun RC; Choi PM; Guo J; Erwin CR; Warner BW
J Pediatr Surg; 2014 Jun; 49(6):966-70; discussion 970. PubMed ID: 24888844
[TBL] [Abstract][Full Text] [Related]
28. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
29. Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.
Koopmann MC; Nelson DW; Murali SG; Liu X; Brownfield MS; Holst JJ; Ney DM
JPEN J Parenter Enteral Nutr; 2008; 32(3):254-65. PubMed ID: 18443137
[TBL] [Abstract][Full Text] [Related]
30. Effect of lactulose on bacterial translocation and intestinal adaptation in a rat model of short bowel syndrome.
Sukhotnik I; Srugo I; Mogilner JG; Lurie M; Coran AG; Shaoul R
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):507-13. PubMed ID: 18493204
[TBL] [Abstract][Full Text] [Related]
31. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
Lai SW; de Heuvel E; Wallace LE; Hartmann B; Holst JJ; Brindle ME; Chelikani PK; Sigalet DL
PLoS One; 2017; 12(7):e0181453. PubMed ID: 28738080
[TBL] [Abstract][Full Text] [Related]
32. The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model.
Koga H; Yang H; Haxhija EQ; Teitelbaum DH
Pediatr Surg Int; 2008 Dec; 24(12):1279-86. PubMed ID: 18989682
[TBL] [Abstract][Full Text] [Related]
33. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects.
Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Sakagami H; Kitsunai H; Takiyama Y; Abiko A; Makino Y; Kieffer TJ; Haneda M
Mol Metab; 2017 Feb; 6(2):226-231. PubMed ID: 28180064
[TBL] [Abstract][Full Text] [Related]
34. mRNA levels of dipeptidyl peptidase IV decrease during intestinal adaptation.
Dunphy JL; Justice FA; Taylor RG; Fuller PJ
J Surg Res; 1999 Nov; 87(1):130-3. PubMed ID: 10527714
[TBL] [Abstract][Full Text] [Related]
35. Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease.
McCormick LM; Kydd AC; Read PA; Ring LS; Bond SJ; Hoole SP; Dutka DP
Circ Cardiovasc Imaging; 2014 Mar; 7(2):274-81. PubMed ID: 24503784
[TBL] [Abstract][Full Text] [Related]
36. [Effects of glucagon-like peptide 2 on the adaptation of residual small bowel in a rat model of short bowel syndrome].
Wu GH; Chen J; Li H; Wu ZH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):441-4. PubMed ID: 17043970
[TBL] [Abstract][Full Text] [Related]
37. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.
Martin GR; Beck PL; Sigalet DL
World J Gastroenterol; 2006 Jul; 12(26):4117-29. PubMed ID: 16830359
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
39. Effect of alpha-naphthylisothiocyanate-induced liver injury on intestinal adaptation in a rat model of short bowel syndrome.
Sukhotnik I; Razon H; Pollak Y; Hayari L; Bejar J; Mogilner JG; Sylvester KG
Pediatr Surg Int; 2012 Feb; 28(2):161-9. PubMed ID: 21989949
[TBL] [Abstract][Full Text] [Related]
40. Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction.
Russell S
Int J Clin Pharm; 2013 Apr; 35(2):159-72. PubMed ID: 23263796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
